Publication | Closed Access
A pilot trial of RNS60 in amyotrophic lateral sclerosis
36
Citations
34
References
2018
Year
Long-term RNS60 administration was safe and well-tolerated. A large, multicenter, phase II trial of RNS60 is currently enrolling participants to test the effects of RNS60 on ALS biomarkers and disease progression. Muscle Nerve 59:303-308, 2019.
| Year | Citations | |
|---|---|---|
Page 1
Page 1